These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16032519)

  • 21. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
    Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
    Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein: a new risk assessment tool for cardiovascular disease.
    Clearfield MB
    J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998.
    Ladwig KH; Marten-Mittag B; Löwel H; Döring A; Koenig W;
    Eur Heart J; 2005 Dec; 26(23):2537-42. PubMed ID: 16126719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study.
    Scheurig AC; Thorand B; Fischer B; Heier M; Koenig W
    Eur J Clin Nutr; 2008 Jan; 62(1):127-37. PubMed ID: 17311055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular phenotypes and functional parameters in the general population--results of the MONICA/KORA studies.
    Schunkert H; Döring A; Kuch B; Holmer S; Luchner A; Muscholl M; Fischer M; Hengstenberg C; Riegger GA; Hense HW;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S74-8. PubMed ID: 16032521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should high sensitive C-reactive protein measurement be included in health screening packages?
    Hawkins RC; Leong L
    Singapore Med J; 2006 Oct; 47(10):837-40. PubMed ID: 16990957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study.
    Meisinger C; Koenig W; Baumert J; Döring A
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1186-92. PubMed ID: 18356554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fractures in the elderly--a challenge for prevention and health promotion--results from the KORA fracture study Augsburg].
    Wildner M; Döring A; Meisinger C; Clark DE
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S180-6. PubMed ID: 16032539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome.
    Roy D; Quiles J; Avanzas P; Arroyo-Espliguero R; Sinha M; Kaski JC
    Int J Cardiol; 2006 May; 109(3):317-21. PubMed ID: 16046018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein (CRP) in the cardiovascular system.
    Kanda T
    Rinsho Byori; 2001 Apr; 49(4):395-401. PubMed ID: 11391955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of out- and inpatient health services by obese adults: a population-based study in the Augsburg region, Germany.
    von Lengerke T; Happich M; Reitmeir P; John J;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S150-7. PubMed ID: 16032534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [C-reactive protein in patients with coronary heart disease].
    Rajtar R; Kolasińska-Kloch W; Kloch M
    Folia Med Cracov; 2004; 45(1-2):25-32. PubMed ID: 16276823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.